SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-16-013440
Filing Date
2016-11-30
Accepted
2016-11-30 16:01:18
Documents
1
Period of Report
2016-11-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_getman113016.html 4  
1 OWNERSHIP DOCUMENT f4_getman113016.xml 4 12367
  Complete submission text file 0001171843-16-013440.txt   13688
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6923 BELINDER AVE MISSION HILLS KS 66208
Business Address
Getman Daniel P (Reporting) CIK: 0001529207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 162025330